Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sinocelltech GroupSHSE:688520 -2.63%54 Days Payable is 351.57 as of Mar. 2026, which is 80% below its 10-year median of 1,741.57. GuruFocus rates SHSE:688520 with a GF Score™ of 54/100 and a GF Value™ of ¥36.51 (Fairly Valued). The stock has 6 warning signs investors should review. Among 702 Biotechnology companies, Sinocelltech Group ranks better than 75.5% on this metric.
The historical rank and industry rank for Sinocelltech Group's Days Payable or its related term are showing as below:
SHSE:688520'
s Days Payable Range Over the Past 10 Years
Min: 233.64 Med: 1741.57 Max: 771412.03
Current: 399.93
During the past 10 years, Sinocelltech Group's highest Days Payable was 771412.03. The lowest was 233.64. And the median was 1741.57.
SHSE:688520's Days Payable is ranked better than 75.5% of 702
companies
in the Biotechnology industry
Industry Median: 113.1
vs SHSE:688520: 399.93
Sinocelltech Group's Days Payable
declined
from Mar. 2025 (459.23) to Mar. 2026 (351.57).
It may suggest that Sinocelltech Groupaccelerated paying its suppliers.
Sinocelltech Group Days Payable Related Terms
Sinocelltech Group Days Payable Historical Data
* Premium members only.
The historical data trend for Sinocelltech Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688520 vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Sinocelltech Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinocelltech Group Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sinocelltech Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Sinocelltech Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sinocelltech Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinocelltech Group (SHSE:688520) has a Days Payable of 351.57 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sinocelltech Group and its competitors. This is 80% below median its historical median of 1,741.57. Over the past decade, Sinocelltech Group's Days Payable has ranged from 233.64 to 771,412.03. According to the industry distribution chart, Sinocelltech Group ranks #172 out of 702 companies in the Biotechnology industry, placing it in the top 24.5%.
Is Sinocelltech Group's Days Payable too high?
Sinocelltech Group's current Days Payable of 351.57 is 80% below median its 10-year median of 1,741.57. Over the past 10 years, this metric has ranged from a low of 233.64 to a high of 771,412.03. The Biotechnology industry median Days Payable is 113.10. Sinocelltech Group's value of 351.57 is 210.8% above this industry median. Based on the distribution chart, Sinocelltech Group ranks #172 out of 702 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Sinocelltech Group has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sinocelltech Group's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sinocelltech Group ranks #172 out of 702 companies for Days Payable. This places Sinocelltech Group in the top 25% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.10. Sinocelltech Group's value of 351.57 is 210.8% above this benchmark. Historically, Sinocelltech Group's own Days Payable has ranged from 233.64 to 771,412.03 over the past decade. While the company's 10-year median is 1,741.57 vs. the industry median of 113.10, Sinocelltech Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sinocelltech Group's current Days Payable of 351.57 is 210.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sinocelltech Group and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sinocelltech Group's current Days Payable is 351.57, which is 80% below median its own 10-year median of 1,741.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinocelltech Group stock overvalued right now?
Based on GuruFocus' analysis, Sinocelltech Group (SHSE:688520) is currently considered Fairly Valued. The stock's GF Value™ is ¥36.51, compared to a current price of ¥35.15 — trading 3.7% below its estimated fair value. The current Days Payable is 351.57, which is 80% below median its 10-year median of 1,741.57 and 210.8% above the Biotechnology industry median of 113.10. Sinocelltech Group's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sinocelltech Group (SHSE:688520), the current Days Payable is 351.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinocelltech Group (SHSE:688520) Overvalued in 2026?
Based on GuruFocus' analysis, Sinocelltech Group stock appears to be undervalued.
The current stock price of ¥35.15 is trading 3.7% below its estimated GF Value™ of ¥36.51.
GuruFocus considers Sinocelltech Group to be Fairly Valued.
Key valuation signals for SHSE:688520:
Days Payable: 351.57 (80% below median its 10-year median of 1,741.57)
GF Value™: ¥36.51 vs. price of ¥35.15 (3.7% below fair value)
Industry Position: 210.8% above the Biotechnology median (#172 of 702)
No single metric tells the full story. See the SHSE:688520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sinocelltech Group Ltd is one of Chin's biopharma companies specializing in biologics and vaccines. The company's therapeutic areas include oncology, immunology and inflammation, ophthalmology, and prophylactic vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. The capabilities of the company include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up, protein purification development, and large scale production.
54GF Score
Get the complete analysis for SHSE:688520
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688520 has been successfully added to your 
